Biomarkers as Game Changers in MS Treatment

18 September 2025 | Zurich, Switzerland

This event highlights the latest advances in personalized medicine in neurology, with a focus on multiple sclerosis (MS). Leading experts will present new findings on the potential of biomarkers to improve diagnosis and guide treatment decisions in MS and neurodegenerative diseases. The program includes scientific talks, clinical insights, and a panel discussion on the future of personalized medicine in neurology.

SPHN's General Manager Thomas Geiger will give a talk on The relevance of personalized medicine in the healthcare system and take part in the panel discussion.